Trial Profile
Pharmacokinetic Study of Propranolol, Losartan, and Eprosartan in Healthy Volunteers and Patients With Chronic Kidney Disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2013
Price :
$35
*
At a glance
- Drugs Eprosartan (Primary) ; Losartan (Primary) ; Propranolol (Primary)
- Indications Angina pectoris; Arrhythmias; Cluster headache; Essential hypertension; Heart failure; Hypertension; Migraine; Tension type headache
- Focus Pharmacokinetics
- 13 Nov 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 13 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Jun 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.